Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia

Prediction of Creatinine Clearance from Serum Creatinine

Donald W. Cockcroft, Henry Gault · ˜The œNephron journals/Nephron journals · 2008 · 15.4K citations

Pharmacy, Nephrology, Pharmacokinetics +15

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Robert W. Finberg, Carola Arndt et al. · New England Journal of Medicine · 1999 · 1.2K citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

Oliver A. Cornely, Johan Maertens, Mark Bresnik et al. · Clinical Infectious Diseases · 2007 · 744 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia

John R. Wingard, Mary H. White, E. Anaissie et al. · Clinical Infectious Diseases · 2000 · 527 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

H. G. Prentice, Ian Hann, Raoul Herbrecht et al. · British Journal of Haematology · 1997 · 438 citations

Medicine, Pharmacology, Pharmacotherapy +17